BioMS Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference



    EDMONTON, Oct. 31 /CNW/ - BioMS Medical Corp (TSX: MS), a leading
developer in the treatment of multiple sclerosis (MS), today announced that
Mr. Kevin Giese, President and CEO, will present at the Acumen BioFin Rodman
and Renshaw 9th Annual Healthcare Conference in New York.

    
    WHEN:  Monday, November 5th at 3:20 pm (Local Time)

    WHERE: New York Palace Hotel, New York
    

    About Acumen BioFin Rodman and Renshaw 9th Annual Healthcare Conference
    -----------------------------------------------------------------------

    The Conference will include presentations by over 350 companies, as well
as experts from the medical, scientific and investment communities. The
Conference will be attended by investors, venture capitalists, company
executives, scientists and other industry leaders.
    For more information visit http://www.rodmanandrenshaw.com/

    About BioMS Medical Corp.
    -------------------------

    BioMS Medical is a biotechnology company engaged in the development and
commercialization of novel therapeutic technologies. BioMS Medical's lead
technology, MBP8298, is for the treatment of multiple sclerosis and is being
evaluated in two pivotal phase III clinical trials for secondary progressive
MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United
States. It additionally is being evaluated for relapsing remitting MS patients
in a Phase II trial in Europe entitled MINDSET-01. For further information
please visit our website at www.biomsmedical.com.

    This news release may contain certain forward-looking statements that
reflect the current views and/or expectations of BioMS Medical with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.





For further information:

For further information: Tony Hesby, Ryan Giese, Corporate
Communications, BioMS Medical Corp., (780) 413-7152, (780) 408-3040 Fax,
E-mail: rgiese@biomsmedical.com, Internet: www.biomsmedical.com; James Smith,
Investor Relations, (416) 815-0700 ext. 229, (416) 815-0080 Fax, E-mail:
jsmith@equicomgroup.com

Organization Profile

Medwell Capital Corp.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890